MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Repurposing Rifabutin for Neuro-Metabolic Disorders: AMPK-PGC-1α-Driven Mitochondrial Protection in Diabetes Associated Parkinsonism

    M I. Khan, D. Ahmed (PRAYAGRAJ, India)

    Objective: To assess the role of rifabutin in restoring mitochondrial function and energy balance through modulation of the AMPK–PGC-1α signaling pathway in diabetes-related Parkinsonism. Background:…
  • 2026 International Congress

    Irisin as a Molecular Mediator of Exercise Induced Neuroprotection and Disease Modification in Parkinson’s Disease

    NIK. Choudhary (Jodhpur, India)

    Objective: To integrate mechanistic evidence delineating irisin mediated molecular pathways relevant to Parkinson’s disease (PD) pathogenesis and neuroprotection, focusing on α-syn clearance, autophagy–lysosomal function, mitochondrial…
  • 2026 International Congress

    Community Gym Exercise Therapy for People Living with Early Onset Parkinson’s Disease

    C. Thwaites, M. Morris, D. Harris, M. Callisaya, R. Mouer, A. Clifford (Bundoora, Australia)

    Objective: To understand the experiences of people living with early onset Parkinson’s disease (EOPD) and exercise trainers regarding the safety, feasibility, acceptability and perceived benefits…
  • 2026 International Congress

    Efficacy of Novel Antipsychotic Agents on Cognitive Functions in Parkinson’s Disease: A Systematic Review and Meta-analysis of 2,533 Patients

    I. Serag (Mansoura, Egypt)

    Objective: To systematically evaluate and quantitatively synthesize evidence on the effects of novel antipsychotic agents (Clozapine, Olanzapine, Risperidone, and Aripiprazole) on cognitive domains in Parkinson’s…
  • 2026 International Congress

    Urate Levels and Risk of Parkinson’s Disease:A Two-Sample Mendelian Randomization Study

    P. Tang, Y. Liu (Xi'an, China)

    Objective: To investigate the causal relationship between circulating serum urate levels and the risk of Parkinson's disease (PD) using a two-sample Mendelian randomization (MR) approach.…
  • 2026 International Congress

    Micro- and Nanoplastics in Parkinson’s Disease Pathogenesis An Emerging Environmental Risk Factor

    A. Aralbayeva, Z. Akhmetzhanova, A. Baidarbekova (Astana, Kazakhstan)

    Objective: To synthesize current experimental and translational evidence supporting the hypothesis that micro- and nanoplastics (MNPs) may contribute to Parkinson’s disease (PD) pathogenesis through neuroinflammatory…
  • 2026 International Congress

    Diet Quality and Nutrient Intake in Parkinson’s Disease: A Multicenter Study in Egypt

    E. Abed (Cairo, Egypt)

    Objective: To compare diet quality and nutrient intake between PD patients and controls and examine associations with PD clinical features. Background: Parkinson’s disease (PD) is…
  • 2026 International Congress

    Clinical Characteristics and Functional Impact of Tremor in Patients with Multiple Sclerosis in Nepal: A Cross-Sectional Observational Study

    AYU. Chandra, AVI. Chandra (Kathmandu, Nepal)

    Objective: To describe the clinical characteristics of tremor in multiple sclerosis (MS) patients in Nepal and assess its functional impact on daily living. To describe…
  • 2026 International Congress

    The Correlation Between Serum Uric Acid Levels And The Severity Of Parkinson’s Disease

    D. Prihananti, E. Pasmanasari (Semarang, Indonesia)

    Objective: This study aims to analyze the correlation between serum uric acid levels and the severity of Parkinson's disease. Background: Uric acid has been implicated…
  • 2026 International Congress

    Quantitative Analysis of Oculomotor Abnormalities in Parkinson’s Disease

    Y. Liu, P. Tang (Xi'an, China)

    Objective: To quantitatively characterize oculomotor abnormalities in patients with Parkinson’s disease (PD) and to evaluate their potential utility for assessing oculomotor dysfunction and supporting early…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley